Redwood Capital Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Redwood Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $2.33 Million - $2.67 Million	-177,815 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $2.29 Million - $2.73 Million	-137,191 Reduced 43.55%	177,815 $3.25 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $8.77 Million - $9.84 Million	-512,949 Reduced 61.95%	315,006 $5.62 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $13.8 Million - $17.8 Million	827,955 New	827,955 $16.9 Million

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Redwood Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Capital Management, LLC with notifications on news.